Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H21NO4.ClH |
Molecular Weight | 351.825 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.O[C@@H](CNCCOC1=CC=C(CC(O)=O)C=C1)C2=CC=CC=C2
InChI
InChIKey=KCEFVYIWOQSJCH-LMOVPXPDSA-N
InChI=1S/C18H21NO4.ClH/c20-17(15-4-2-1-3-5-15)13-19-10-11-23-16-8-6-14(7-9-16)12-18(21)22;/h1-9,17,19-20H,10-13H2,(H,21,22);1H/t17-;/m0./s1
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C18H21NO4 |
Molecular Weight | 315.3636 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Talibegron (ZD2079) is a β3 adrenoceptor agonist and insulin sensitiser. It was developed as a potential treatment for obesity and non-insulin-dependent diabetes mellitus. Talibegron hydrochloride had been in phase II clinical trials by AstraZeneca for the treatment of type 2 diabetes and obesity. However, this research has been discontinued.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10207980
Rats: Male and female rats were dosed separately by gavage for a minimum of 28 days with 0, 10, 30, and 150 mg/kg/day of Talibegron (ZD2079).
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10511470
Talibegron (ZD2079) produced a concentration-dependent (10(-6)M - 10(-3)M) relaxation of the rat isolated carotid artery rings preconstricted with U-46619.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:40:26 GMT 2023
by
admin
on
Fri Dec 15 15:40:26 GMT 2023
|
Record UNII |
N251Q608VU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C48149
Created by
admin on Fri Dec 15 15:40:27 GMT 2023 , Edited by admin on Fri Dec 15 15:40:27 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
MM-66
Created by
admin on Fri Dec 15 15:40:27 GMT 2023 , Edited by admin on Fri Dec 15 15:40:27 GMT 2023
|
PRIMARY | |||
|
158793
Created by
admin on Fri Dec 15 15:40:27 GMT 2023 , Edited by admin on Fri Dec 15 15:40:27 GMT 2023
|
PRIMARY | |||
|
CHEMBL1616411
Created by
admin on Fri Dec 15 15:40:27 GMT 2023 , Edited by admin on Fri Dec 15 15:40:27 GMT 2023
|
PRIMARY | |||
|
300000028994
Created by
admin on Fri Dec 15 15:40:27 GMT 2023 , Edited by admin on Fri Dec 15 15:40:27 GMT 2023
|
PRIMARY | |||
|
178600-17-4
Created by
admin on Fri Dec 15 15:40:27 GMT 2023 , Edited by admin on Fri Dec 15 15:40:27 GMT 2023
|
PRIMARY | |||
|
N251Q608VU
Created by
admin on Fri Dec 15 15:40:27 GMT 2023 , Edited by admin on Fri Dec 15 15:40:27 GMT 2023
|
PRIMARY | |||
|
C77937
Created by
admin on Fri Dec 15 15:40:27 GMT 2023 , Edited by admin on Fri Dec 15 15:40:27 GMT 2023
|
PRIMARY | |||
|
DTXSID8049042
Created by
admin on Fri Dec 15 15:40:27 GMT 2023 , Edited by admin on Fri Dec 15 15:40:27 GMT 2023
|
PRIMARY | |||
|
C102383
Created by
admin on Fri Dec 15 15:40:27 GMT 2023 , Edited by admin on Fri Dec 15 15:40:27 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |